tiprankstipranks
Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Financial Statements

Compare
257 Followers

Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently $562.21M. The company's EPS TTM is $-2.254; its P/E ratio is ―; Nuvation Bio is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 7.87M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 795.00K$ -222.00K$ -484.00K$ -368.00K$ -103.00K
Operating Income$ -592.63M$ -99.82M$ -119.73M$ -93.32M$ -43.55M
EBITDA$ -566.91M$ -99.60M$ -119.53M$ -89.35M$ -43.45M
Net Income$ -567.94M$ -75.80M$ -88.66M$ -79.73M$ -39.50M
Balance Sheet
Cash & Short-Term Investments$ 502.69M$ 611.21M$ 661.01M$ 765.39M$ 215.75M
Total Assets$ 540.63M$ 621.48M$ 672.14M$ 776.15M$ 221.79M
Total Debt$ 8.91M$ 4.01M$ 4.26M$ 3.06M$ 0.00
Net Debt$ -26.81M$ -38.64M$ -96.84M$ -129.37M$ -29.75M
Total Liabilities$ 76.84M$ 16.36M$ 17.07M$ 30.15M$ 6.71M
Stockholders' Equity$ 463.79M$ 605.12M$ 655.08M$ 746.00M$ 215.08M
Cash Flow
Free Cash Flow$ -130.57M$ -68.07M$ -96.48M$ -68.47M$ -36.67M
Operating Cash Flow$ -130.41M$ -68.00M$ -96.11M$ -68.19M$ -36.53M
Investing Cash Flow$ 122.70M$ 8.92M$ 63.46M$ -454.67M$ -70.32M
Financing Cash Flow$ 331.00K$ 628.00K$ 1.33M$ 625.53M$ 133.13M
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis